Celltrion
068270.KS
#786
Rank
HK$241.96 B
Marketcap
HK$1,106
Share price
-0.71%
Change (1 day)
16.64%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): HK$14.75

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$14.76. In 2023 the company made an earnings per share (EPS) of HK$21.58 a decrease over its 2022 EPS that were of HK$22.03.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$14.75
2023HK$21.58-2.08%
2022HK$22.03-11.72%
2021HK$24.962.03%
2020HK$24.4682.8%
2019HK$13.3818.31%
2018HK$11.31-36.33%
2017HK$17.76161.25%
2016HK$6.802.86%
2015HK$6.6117.84%
2014HK$5.615.87%
2013HK$5.30-70.85%
2012HK$18.18134.09%
2011HK$7.7743.59%
2010HK$5.4174.49%
2009HK$3.10317.8%
2008HK$0.74-71.7%
2007HK$2.62